NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

冠状病毒疫苗的市场规模:各疫苗类型、地区 - 占有率,预测,机会分析(2020年~2027年)

Corona Virus Vaccine Market, by Vaccine Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品编码 980005
出版日期 内容资讯 英文 201 Pages
商品交期: 2-3个工作天内
价格
冠状病毒疫苗的市场规模:各疫苗类型、地区 - 占有率,预测,机会分析(2020年~2027年) Corona Virus Vaccine Market, by Vaccine Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月22日内容资讯: 英文 201 Pages
简介

全球冠状病毒疫苗的市场,由于为了增加COVID-19疫苗的生产与流通,主要企业和政府的联盟和合作等无机性成长策略的采用增加,预计在预测期间内推动成长。

各国的政府,为了行销和商品化法规当局确实已批准COVID-19疫苗,确保迅速生产与流通而采取行动。

本报告提供全球冠状病毒疫苗市场的相关调查,市场机会和趋势,成长及阻碍因素,各疫苗类型、地区的市场分析,竞争情形,主要企业的简介等资讯。

目录

第1章 调查目的、前提条件

第2章 市场展望

  • 报告概要
    • 市场定义和范围
  • 摘要整理
    • 市场明细:各疫苗类型
    • 市场明细:各地区
  • Coherent Opportunity Map (COM)

第3章 市场动态,法规,及趋势分析

  • 热图分析
  • 市场动态
    • 成长要素
    • 阻碍因素
    • 市场机会
  • 法规方案
  • 产业趋势
  • 合并和收购
  • 新的疫苗型式核准/销售
  • 推销及行销举措
  • PEST分析

第4章 市场分析:各疫苗类型(2016-2027)

  • 简介
  • 不活化病毒
  • 蛋白质次单元
  • 非复制型病毒载体
  • 再利用疫苗
  • RNA疫苗
  • DNA疫苗
  • 遗传基因疫苗

第2章 市场分析:各地区(2016-2027)

  • 简介
  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第3章 竞争情形

  • 热图分析
  • 市场占有率分析
    • AstraZeneca plc
    • Pfizer Inc.
    • Sanofi SA
    • Novavax, Inc.
    • Moderna, Inc.
    • Sinovac Biotech Ltd.
    • Bharat Biotech International Limited
    • Johnson & Johnson
    • BioNTech SE
    • Serum Institute of India
    • Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • CanSino Biologics Inc.
    • CureVac AG
    • Cadila Healthcare Limited
    • Arcturus Therapeutics Holdings Inc.
    • Entos Pharmaceuticals
    • Symvivo
  • 分析师的见解

第4章 Section

目录

Title:
Corona Virus Vaccine Market, by Vaccine Type (Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed Vaccines, RNA Vaccine, DNA Vaccine, and Genetic Vaccines), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Government of various countries are taking actions, in order to ensure the rapid production and delivery of the COVID-19 vaccines once approved by regulatory authorities for marketing and commercialization. For instance, on May 15, 2020, the U.S. government announced Framework and Leadership for 'Operation Warp Speed', a national program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics (medical countermeasures) in the U.S. The Operation Warp Speed's goal is to produce and deliver around 300 million doses of safe and effective COVID-19 vaccines with the initial doses available by January 2021 in the U.S. The Operation Warp Speed (OWS) is formed by the partnership of Department of Health and Human Services (HHS) such as Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), and the Department of Defense (DoD).

Market Dynamics

The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players, as well as by the government to increase the production and distribution of COVID-19 vaccines are expected to propel the market growth during the forecast period. For instance, on August 14, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) entered into an agreement with Moderna, Inc., to manufacture and deliver 100 million doses of COVID-19 vaccines produced by the company in the U.S by 2021.

Similarly, on October 16, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) entered into an agreement with CVS and Walgreens to provide and administer COVID-19 vaccines to residents of long-term care facilities (LTCF) in the U.S. with no out-of-pocket costs.

Key features of the study:

  • This report provides in-depth analysis of the global corona virus vaccine market and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global corona virus vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include AstraZeneca plc, Pfizer Inc., Sanofi S.A., Novavax, Inc., Moderna, Inc., Sinovac Biotech Ltd., Bharat Biotech International Limited, Johnson & Johnson, BioNTech SE, Serum Institute of India, Shanghai Fosun Pharmaceutical Group Co., Ltd., CanSino Biologics Inc., CureVac AG , Cadila Healthcare Limited, Arcturus Therapeutics Holdings Inc., Entos Pharmaceuticals, and Symvivo.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, Specimen Type up-gradation, market expansion, and marketing tactics
  • The global corona virus vaccine market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global corona virus vaccine market

Detailed Segmentation:

  • Global Corona Virus Vaccine Market, By Vaccine Type:
    • Inactivated Virus
    • Protein Subunit
    • Non-replicating Viral Vector
    • Repurposed Vaccines
    • RNA Vaccine
    • DNA Vaccine
    • Genetic Vaccines
  • Global Corona Virus Vaccine Market, By Region:
    • North America
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • AstraZeneca plc*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
    • Sanofi S.A.
    • Novavax, Inc.
    • Moderna, Inc.
    • Sinovac Biotech Ltd.
    • Bharat Biotech International Limited
    • Johnson & Johnson
    • BioNTech SE
    • Serum Institute of India
    • Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • CanSino Biologics Inc.
    • CureVac AG
    • Cadila Healthcare Limited
    • Arcturus Therapeutics Holdings Inc.
    • Entos Pharmaceuticals
    • Symvivo

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Industry Trend
  • Merger and Acquisitions
  • New Vaccine Type Approvals/Launch
  • Promotion and Marketing Initiatives
  • PEST Analysis

4. Global Corona Virus Vaccine Market, By Vaccine Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Inactivated Virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Protein Subunit
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Non-replicating Viral Vector
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Repurposed Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • RNA Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • DNA Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Genetic Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

2. Global Corona Virus Vaccine Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

3. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • AstraZeneca plc
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novavax, Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Moderna, Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sinovac Biotech Ltd.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bharat Biotech International Limited
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BioNTech SE
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Serum Institute of India
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CanSino Biologics Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CureVac AG
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cadila Healthcare Limited
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Arcturus Therapeutics Holdings Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Entos Pharmaceuticals
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Symvivo
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

4. Section

  • References
  • Research Methodology
  • About Us and Sales Contact